OsNovum

We improve skeletal health to extend lifespan and increase quality of life
Henderson, 
NV
Investment type:
Equity
(Priced Round)
Target raise:
$60,750
 - 1,070,000
Minimum investment:​
$100
End date:
Feb 06, 2021
Share
Share on facebook
Share on twitter
Share on linkedin
Share on email
Highlights

  • OsNovum founders own the patent to this technology
  • Already FDA-cleared for maxillofacial use, streamlining the track to clearance in the skeleton
  • Disruptive new technology for the $73B osteoporosis treatment industry
Our Story

OsNovum has developed the technology to regenerate bone to maintain skeletal health. Weak bones are a major reason for frailty as we age. OsNovum has the proven technology to regenerate bone but will also open clinics devoted exclusively to skeletal heath and the prevention of frailty as we age.
Our Ambition

In one year, we hope to introduce our technology to medicine for bone regeneration and open the initial clinics devoted to skeletal health. After three years, we hope to show significant revenue growth and plan a public offering to expand OsNovum clinics worldwide. In 5 years, we hope that OsNovum will be recognized as the world leader in maintaining skeletal health with treatment facilities worldwide. These are forward looking projections and are not guaranteed.